Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, β-lactamase distribution, phylogroups, and co-resistance

  • Dennis Schrøder Hansen
  • , Helga Schumacher
  • , Frank Hansen
  • , Marc Stegger
  • , Frederik Boëtius Hertz
  • , Kristian Schønning
  • , Ulrik Stenz Justesen
  • , Niels Frimodt-Møller
  • , DANRES Study Group

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

Most Gram-negative community-acquired and nosocomial infections are caused by Escherichia coli and Klebsiella pneumoniae, among which increasing resistance due to extended-spectrum β-lactamase (ESBL) is a major problem. We present data from the first Danish nationwide prevalence study on ESBL-producing E. coli, K. pneumoniae, and Proteus mirabilis in blood and urine cultures from hospitals and the community.
OriginalsprogEngelsk
TidsskriftScandinavian Journal of Infectious Diseases
Vol/bind44
Udgave nummer3
Sider (fra-til)174-81
Antal sider8
ISSN0036-5548
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, β-lactamase distribution, phylogroups, and co-resistance'. Sammen danner de et unikt fingeraftryk.

Citationsformater